FDA Plans Warning on J&J Vaccine for Autoimmune Disorder

Published on July 12, 2021

Johnson & Johnson said Monday it was in discussions with the U.S. Food and Drug Administration about rare cases of a neurological disorder, Guillain-BarreĢ syndrome, that have been reported following vaccination with the Janssen COVID-19 vaccine.

Read Full Article (External Site)